Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein

Oncogene volume 18, pages 6477–6487 (1999)Cite this article

Abstract

We previously reported cloning the rLot1 gene, and its human homolog (hLOT1), through analysis of differential gene expression in normal and malignant rat ovarian surface epithelial cells. Both human and rat ovarian carcinoma cell lines exhibited lost or decreased expression of this gene. Interestingly, the LOT1 gene localized at band q25 of human chromosome 6 which is a frequent site for LOH in many solid tumors including ovarian cancer. In this report we have further characterized the potential role of LOT1 in malignant transformation and developed evidence that the gene is a novel target of growth factor signaling pathway. Assays using transient transfections showed that LOT1 is a nuclear protein and may act as a transcription factor. In vitro and in vivo studies involving ovarian cancer cell lines revealed that expression of LOT1 is directly associated with inhibition of cellular proliferation and induction of morphological transformations. Additionally, we show that in normal rat ovarian surface epithelial cells Lot1 gene expression is responsive to growth factor stimulation. Its mRNA is strongly down-regulated by epidermal growth factor receptor (EGFR) ligands, namely EGF and TGF-α. Blocking the ligand-activated EGFR signal transduction pathway by the specific EGF receptor inhibitor, tyrphostin AG1478, and the MEK inhibitor, PD098059, restores the normal level of Lot1 gene expression. It appears that the regulation of Lot1 gene is unique to these ligands, as well as the growth promoting agent TPA, since other factors either did not affect Lot1 expression, or the effect was modest and transient. Altogether, the results suggest that Lot1 expression is primarily mediated via EGF receptor or a related pathway and it may regulate the growth promoting signals as a zinc-finger motif containing nuclear transcription factor.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 10
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Aaronson S. . 1991 Science 254: 1146–1153.

  • Abdollahi A, Getts L, Sonoda G, Miller P, Taguchi T, Godwin A, Testa and Hamilton T. . 1999 J. Soc. Gynecol. Invest. 6: 32–40.

  • Abdollahi A, Godwin A, Miller P, Getts L, Schultz D, Taguchi T, Testa J and Hamilton T. . 1997a Cancer Res. 57: 2029–2034.

  • Abdollahi A, Lord K, Hoffman-Liebermann B and Liebermann D. . 1991 Oncogene 6: 165–167.

  • Abdollahi A, Roberts D, Godwin A, Schultz D, Sonoda G, Testa J and Hamilton T. . 1997b Oncogene 14: 1973–1979.

  • Aharonov A, Pruss R and Herschman H. . 1978 J. Biol. Chem. 253: 3970–3977.

  • Ahn N, Weiel J, Chan C and Krebs E. . 1990 J. Biol. Chem. 265: 11487–11494.

  • Alessandrini A, Crews C and Erikson R. . 1992 Proc. Natl. Acad. Sci. USA 89: 8200–8204.

  • Ames G and Gold L. . 1990 Proc. Natl. Acad. Sci. USA 87: 7772–7776.

  • Arends M and Wyllie A. . 1991 Int. Rev. Exp. Pathol. 32: 223–254.

  • Batt D and Roberts T. . 1998 J. Biol. Chem. 273: 3408–3414.

  • Bauknecht T, Kiechle M, Bauer G and Siebers J. . 1986 Cancer Res. 46: 2614–2618.

  • Berchuck A, Olt G, Everitt L, Soisson A, Bast R and Boyer C. . 1990 Obstet. Gynecol. 75: 255–262.

  • Brent R and Ptashne M. . (1985) Cell 43: 729–736.

  • Cano E, Hazzalin C and Mahadevan L. . 1994 Mol. Cell. Biol. 14: 7352–7362.

  • Carpenter G. . 1981 Hdbk. Exp. Pharmacol. 57: 90–126.

  • Carpenter G and Cohen S. . 1976 J. Cell Physiol. 88: 227–238.

  • Casagrande J, Pike C, Ross R, Louie E, Roy S and Henderson B. . 1979 Lancet ii: 170–173.

  • Casillas A, Amaral K, Chegini-Fraahani S and Nel A. . 1993 Biochem. J. 290: 545–550.

  • Cheng A, Balczon R, Zuo Z, Koons J, Walsh A and Honkanen R. . 1998 Cancer Res. 58: 3611–3619.

  • Chomczynski P and Sacchi N. . 1987 Analyt. Biochem. 162: 156–159.

  • Cohen P, Holmes C and Tsukitami Y. . 1990 Trends Biochem. Sci. 15: 98–102.

  • Colitti C, Rodabaugh K, Welch W, Berkowitz R and Mok S. . 1998 Oncogene 16: 555–559.

  • Coughlin S, Lee W, Williams P, Giels G and Williams L. . 1985 Cell 43: 243–251.

  • Courney A and Tijan R. . 1988 Cell 55: 741–753.

  • Derynck R. . 1998 Cell 54: 593–595.

  • Dingwall C, Sharnick S and Laskey R. . 1982 Cell 30: 449–458.

  • Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J and Waterfield M. . 1984 Nature 307: 521–527.

  • Dudley D, Pang L, Decker S, Bridges A and Saltiel A. . 1995 Proc. Natl. Acad. Sci. USA 92: 7686–7689.

  • Emkey R and Kahn C. . 1997 J. Biol. Chem. 49: 31172–31181.

  • Eskrand A, Longo N, Hamid M, Olson J, Liu L, Collins V and James C. . 1994 Oncogene 9: 2313–2320.

  • Fathalla M. . 1971 Lancet ii: 163.

  • Fry D, Kraker A, McMichael A, Ambroso L, Nelson J, Leopold W, Connors R and Bridges A. . 1994 Science 265: 1093–1095.

  • Fujii H, Zhou W and Gabrielson E. . 1996 Genes Chromosomes Cancer 16: 35–39.

  • Godwin A, Testa J, Handel L, Liu Z, Vandeveer L, Tracey P and Hamilton T. . 1992 J. Natl. Cancer Inst. 84: 592–601.

  • Gonzalez F, Raden D and Davis R. . 1991 J. Biol. Chem. 266: 22159–22163.

  • Gotoh N, Tojo A, Muroya K, Hashimoto Y, Hattori S, Nakamura S, Takenaw T, Yazaki Y and Shibuya M. . 1994 Proc. Natl. Acad. Sci. USA 91: 167–171.

  • Grimes H, Chan T, Zweidler-McKay P, Tong B and Tsichlis P. . 1996 Mol. Cell. Biol. 16: 6263–6272.

  • Hazzalin C, Panse R, Cano E and Mahadevan L. . 1998 Mol. Cell. Biol. 18: 1844–1854.

  • Henderson B, Ross R and Pike M. . 1991 Science 254: 1131–1138.

  • Howe L, Leevers S, Gomez N, Nakielny S, Cohen P and Marshal C. . 1992 Cell 71: 335–342.

  • Hunter T. . 1984 Nature 311: 414–416.

  • Hunter T. . 1995 Cell 80: 225–236.

  • Ilekis J, Gariti J, Niederberger C and Scoccia B. . 1997 Gynecol. Oncol. 65: 36–41.

  • Jans D and Hassan G. . 1998 BioEssays 20: 400–411.

  • Kampfer S, Hellbert K, Villunger A, Doppler W, Baier G, Grunicke H and Uberall F. . 1998 EMBO J. 17: 4046–4055.

  • Kas K, Voz M, Hensen K, Meyen E and Van de ven W. . 1998 J. Biol. Chem. 273: 23026–23032.

  • Kas K, Voz M, Roijer E, Astrom A-K, Meyen E, Stenman G and Van de Ven W. . 1997 Nature Genetics 15: 170–174.

  • Kommoss F, Wintzer H, Von Kleist S, Kohler M, Walker R, Langton B, Tran K, Pfleiderer A and Bauknecht T. . 1990 J. Pathol. 162: 223–230.

  • Kyriakis J, Banerjee P, Nikolakaki E, Dai T, Rubie E, Ahmad M, Abruch J and Woodgett J. . 1994 Nature 369: 156–160.

  • Li S, Ku C-Y, Farmer A, Cong Y-S, Chen C-F and Lee W-H. . 1998 J. Biol. Chem. 273: 6183–6189.

  • Liebermann T, Nusbaum H, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield M, Ullrich A and Schlessinger J. . 1985 Nature 313: 144–147.

  • Lord K, Abdollahi A, Hoffman-Liebermann B and Liebermann D. . 1991 Cell Growth Diff. 1: 637–645.

  • Lord K, Abdollahi A, Hoffman-Liebermann B and Liebermann D. . 1993 Mol. Cell. Biol. 13: 841–851.

  • Maniatis T, Fritsch E and Sambrook J. . 1989 Molecular cloning: A laboratory manual., 2nd edn. Cold Spring Harbor Laboratory.

    Google Scholar 

  • Massague J. . 1983 J. Biol. Chem. 258: 13614–13620.

  • Mellon K, Wright C, Kelly P, Horne C and Neal D. . 1995 J. Urol. 153: 919–925.

  • Mermod N, O'Neill E, Kelly T and Tijan R. . 1988 Cell 58: 741–753.

  • Moon S, Palfrey H and King A. . 1984 Proc. Natl. Acad. Sci. USA 81: 2298–2302.

  • Moreno S and Nurse P. . 1990 Cell 61: 549–551.

  • Morishige K, Kurachi H, Amemiya K, Fujita Y, Yamamoto Y, Miyake A and Tanizawa O. . 1991 Cancer Res. 51: 5322–5328.

  • Moscatello D, Holgadomadruga M, Godwin A, Ramirez G, Gunn G, Zoltick P, Biegel J, Hayes R and Wong A. . 1995 Cancer Res. 55: 5536–5539.

  • Nomura N, Nagase T, Miyajima N, Sazuka T, Tanaka A, Sato S, Seki N, Kawarabayas Y, Ishikawa K and Tabata S. . 1994 DNA Res. 1: 223–229.

  • Pardee A. . 1989 Science 246: 603–608.

  • Petch L, Harris J, Raymond V, Blasband A, Lee D and Earp H. . 1990 Mol. Cell. Biol. 10: 2973–2982.

  • Pontecorvi A, Tata J, Pylillaier M and Robbins J. . 1988 EMBO J. 7: 1489–1495.

  • Preston-Martin S, Pike M, Ross R, Jones P and Henderson B. . 1990 Cancer Res. 50: 7415–7421.

  • Rani C, Wang F, Fuir E, Berger A, Wu J, Sturgill T, Beitner-Johnson D, LeRoith D, Varticovski L and Spiegel S. . 1997 J. Biol. Chem. 272: 10777–10783.

  • Roberts D, Weinstein J, Abdollahi A and Hamilton T. . 1999 Submitted for publication.

  • Rodriguez G, Berchuck A, Whitaker R, Schlossman D, Clarke-Pearson D and Bast R. . 1991 Am. J. Obstet. Gynecol. 164: 745–750.

  • Sainsbury J, Frandon J, Sherbert G and Harris A. . 1985 Lancet I: 364–366.

  • Scambia G, Benedetti-Panici P, Battaglia F, Ferrandina G, Briocchi G, Greggi S, deVincenzo R and Mancuso S. . 1992 J. Clin. Oncol. 10: 529–535.

  • Schlessinger J and Ullrich A. . 1992 Neuron 9: 383–391.

  • Shechter Y, Hernaez L and Cuatrecasas P. . 1978 Proc. Natl. Acad. Sci. USA 75: 5788–5791.

  • Spengler D, Villalba M, Hoffman A, Pantaloni C, Houssami S, Bockaert J and Journet L. . 1997 EMBO J. 16: 2814–2825.

  • Suganuma M, Fujiki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatsu K, Yamada K and Sugimura T. . 1988 Proc. Natl. Acad. Sci. USA 85: 1768–1771.

  • Tenaka K, Boice C and Testa J. . 1989 Cancer Genet. Cytogenet. 43: 1–14.

  • Testa J, Getts L, Salazar H, Liu Z, Handel L, Godwin A and Hamilton T. . 1994 Cancer Res. 54: 2778–2784.

  • Thrash-Bingham C, Salazar H, Freed J, Greenberg R and Tartof K. . 1995 Cancer Res. 55: 6189–6195.

  • Ullrich A and Schlessinger J. . 1990 Cell 61: 203–212.

  • Weinberg R. . 1991 Science 254: 1138–1146.

  • Williamson M. . 1994 Biochem. J. 297: 249–260.

  • Xu Y-H, Ishii S, Clark A, Sullivan M, Wilson R, Ma D, Roe B, Merlino G and Pastan I. . 1984 Nature 309: 806–810.

  • Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S and Shimizu N. . 1986 Cancer Res. 46: 414–416.

  • Zheng C-F and Guan K. . 1993 J. Biol. Chem. 268: 11435–11439.

  • Zhou L and Padmanabhan R. . 1988 Cell 55: 1005–1015.

Download references

Acknowledgements

We are grateful to H Leighton Grimes, Andrew Godwin, Joseph Testa, Philip Tsichlis, Jun-Hsiang Lin and Yasuhiro Mitsuuchi for helpful discussions, and Daphne Bell, Binaifer Balsara, and Jonathan Boyd for confocal microscopy and image analysis, and Cathy Thompson for secretarial work. This research was supported by Public Health service grant CA56916/TC Hamilton.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Ovarian Cancer Program, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, 19111, Pennsylvannia, PA, USA

    Abbas Abdollahi, Rudi Bao & Thomas C Hamilton

Authors
  1. Abbas Abdollahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rudi Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas C Hamilton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdollahi, A., Bao, R. & Hamilton, T. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene 18, 6477–6487 (1999). https://doi.org/10.1038/sj.onc.1203067

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203067

Keywords

This article is cited by

Search

Advanced search

Quick links